We aimed to evaluate the diagnostic performance of GPR for liver fibrosis in patients with chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene ALDH18A1 and chronic hepatitis B virus infection.